| A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds A Cumashi, NA Ushakova, ME Preobrazhenskaya, A D'Incecco, A Piccoli, ... Glycobiology 17 (5), 541-552, 2007 | 1207 | 2007 |
| Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? GA Rabinovich, LG Baum, N Tinari, R Paganelli, C Natoli, FT Liu, ... Trends in immunology 23 (6), 313-320, 2002 | 733 | 2002 |
| Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. P Patrignani, MR Panara, A Greco, O Fusco, C Natoli, S Iacobelli, ... Journal of Pharmacology and Experimental Therapeutics 271 (3), 1705-1712, 1994 | 647 | 1994 |
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … SM Swain, D Miles, SB Kim, YH Im, SA Im, V Semiglazov, E Ciruelos, ... The Lancet Oncology 21 (4), 519-530, 2020 | 631 | 2020 |
| Chronomodulated versus fixed-infusion—rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (Leucovorin) in patients with colorectal cancer … FA Lévi, R Zidani, JM Vannetzel, B Perpoint, C Focan, R Faggiuolo, ... JNCI: Journal of the National Cancer Institute 86 (21), 1608-1617, 1994 | 454 | 1994 |
| Concentrations of galectin-3 in the sera of normal controls and cancer patients I Iurisci, N Tinari, C Natoli, D Angelucci, E Cianchetti, S Iacobelli Clinical cancer research 6 (4), 1389-1393, 2000 | 428 | 2000 |
| Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg388 Allele J Bange, D Prechtl, Y Cheburkin, K Specht, N Harbeck, M Schmitt, ... Cancer research 62 (3), 840-847, 2002 | 385 | 2002 |
| Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties P Matarrese, O Fusco, N Tinari, C Natoli, FT Liu, ML Semeraro, W Malorni, ... International journal of cancer 85 (4), 545-554, 2000 | 342 | 2000 |
| Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer T Rich, PF Innominato, J Boerner, MC Mormont, S Iacobelli, B Baron, ... Clinical cancer research 11 (5), 1757-1764, 2005 | 302 | 2005 |
| Increased levels of soluble P-selectin in hypercholesterolemic patients G Davı, M Romano, A Mezzetti, A Procopio, S Iacobelli, T Antidormi, ... Circulation 97 (10), 953-957, 1998 | 266 | 1998 |
| Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate F Levi, B Perpoint, C Garufi, C Focan, P Chollet, P Depres-Brummer, ... European Journal of Cancer 29 (9), 1280-1284, 1993 | 252 | 1993 |
| Effects of light and food schedules on liver and tumor molecular clocks in mice E Filipski, PF Innominato, MW Wu, XM Li, S Iacobelli, LJ Xian, F Lévi Journal of the National Cancer Institute 97 (7), 507-517, 2005 | 247 | 2005 |
| Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer PF Innominato, C Focan, T Gorlia, T Moreau, C Garufi, J Waterhouse, ... Cancer research 69 (11), 4700-4707, 2009 | 231 | 2009 |
| Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic … S Giacchetti, G Bjarnason, C Garufi, D Genet, S Iacobelli, M Tampellini, ... Journal of clinical oncology 24 (22), 3562-3569, 2006 | 229 | 2006 |
| 90K (Mac-2 BP) and galectins in tumor progression and metastasis A Grassadonia, N Tinari, I Iurisci, E Piccolo, A Cumashi, P Innominato, ... Glycoconjugate journal 19, 551-556, 2002 | 216 | 2002 |
| Galectin‐3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis P Matarrese, N Tinari, ML Semeraro, C Natoli, S Iacobelli, W Malorni FEBS letters 473 (3), 311-315, 2000 | 199 | 2000 |
| Phospholipase Cγ1 is required for metastasis development and progression G Sala, F Dituri, C Raimondi, S Previdi, T Maffucci, M Mazzoletti, C Rossi, ... Cancer research 68 (24), 10187-10196, 2008 | 177 | 2008 |
| Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects T Maffucci, E Piccolo, A Cumashi, M Iezzi, AM Riley, A Saiardi, ... Cancer Research 65 (18), 8339-8349, 2005 | 171 | 2005 |
| Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer S Iacobelli, E Arnò, A D'Orazio, G Coletti Cancer research 46 (6), 3005-3010, 1986 | 165 | 1986 |
| Glycoprotein 90K/MAC‐2BP interacts with galectin‐1 and mediates galectin‐1–induced cell aggregation N Tinari, I Kuwabara, ME Huflejt, PF Shen, S Iacobelli, FT Liu International journal of cancer 91 (2), 167-172, 2001 | 154 | 2001 |
